Clinical trials sponsored by Institute of Oncology Ljubljana

Phase breakdown

Conditions studied

Recruiting trials led by Institute of Oncology Ljubljana

• Biomarkers in Immunotherapy of Melanoma
  NCT05878977 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC)
  NCT07407231 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study
  NCT06923787 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study)
  NCT07432399 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers
  NCT07407166 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma
  NCT07404605 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immunotherapy
  NCT07761871 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia
  NCT07422779 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer
  NCT06648148 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
  NCT07418125 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients
  NCT07416630 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Institute of Oncology Ljubljana recruiting for?

Institute of Oncology Ljubljana is the lead sponsor of 11 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.